Inicio › Carcinoma de células escamosas de cabeza y cuello › Virginia › Arlington
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Arlington, VA
26 estudios para Carcinoma de células escamosas de cabeza y cuello buscan participantes en centros de Arlington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
ReclutandoFase 1
- Site 04, Fairfax · A 11 mi de distancia
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ReclutandoFase 1
- ALX Center 2, Fairfax · A 11 mi de distancia
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutandoFase 2
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ReclutandoFase 1/2
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ReclutandoFase 2
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site, Fairfax · A 11 mi de distancia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Fairfax · A 11 mi de distancia
A Study of DM005 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · A 11 mi de distancia
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- NEXT, Fairfax · A 11 mi de distancia
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
ReclutandoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · A 11 mi de distancia
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
ReclutandoFase 1
- NEXT Texas LLC - Virginia, Fairfax · A 11 mi de distancia
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
ReclutandoFase 1
- Dren Investigational Site, Fairfax · A 11 mi de distancia
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site 102, Fairfax · A 11 mi de distancia
- Research Site 112, Fairfax · A 11 mi de distancia
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Ensayos de Carcinoma de células escamosas de cabeza y cuello en otras ciudades
- Houston, TX47 estudios
- Los Angeles, CA42 estudios
- Boston, MA40 estudios
- Nashville, TN39 estudios
- New York City, NY39 estudios
- St. Louis, MO28 estudios
- Chicago, IL26 estudios
- Philadelphia, PA26 estudios
- Atlanta, GA24 estudios
- San Antonio, TX22 estudios
- Pittsburgh, PA22 estudios
- New Haven, CT22 estudios
Otros estudios en Arlington
- Cáncer de pulmón de células no pequeñas104 estudios
- Cáncer metastásico53 estudios
- Cáncer del colon y del recto52 estudios
- Cáncer (todos los tipos)48 estudios
- Cáncer de seno47 estudios
- Cáncer de ovario46 estudios
- Cáncer de pulmón41 estudios
- Cáncer de endometrio39 estudios
- Cáncer de páncreas33 estudios
- Cáncer de pulmón de células pequeñas23 estudios
- Cáncer de estómago20 estudios
- Cáncer de mama triple negativo20 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.